These three articles are for men who have just been told they have prostate cancer, and for the people supporting them. Read them in order: the first covers what the diagnosis means, the second explains your test results, and the third walks through treatment choices. They are general information, not medical advice; your own care team knows your case best.
Article 1: You’ve Been Diagnosed. Now What?
Most men diagnosed with prostate cancer do not die from it. That is the single most important fact to hold onto in the first days. In the US, about 69% of cases are found while the cancer is still inside the prostate, and the 5-year relative survival for that group is essentially 100% (SEER). The Canadian Cancer Society reports the same picture: close to 100% for localized disease (cancer.ca).
That does not make the news easy to hear. Shock, fear, anger and numbness are all normal. The goal of this article is to give you enough footing to take the next step calmly.
What the prostate is
The prostate is a walnut-sized gland below the bladder, wrapped around the tube that carries urine (the urethra). It makes part of the fluid in semen. Because of where it sits, prostate cancer and its treatments can affect urination, erections and bowel function. Those effects are the main things you will weigh when choosing treatment.
Why prostate cancer is different
Prostate cancer is not one disease with one speed. Many prostate cancers grow so slowly that they never cause symptoms or shorten life. Others are aggressive and need prompt treatment. Much of your next few weeks will be spent working out which kind you have.
This is why some men are advised to monitor their cancer instead of treating it right away. That advice is not a brush-off. For low-risk cancer, careful monitoring is a recognized first choice that spares men side effects they may never need to face.
You almost always have time
For most newly diagnosed men, there is no emergency. A few weeks spent getting more tests, a second opinion, or simply thinking things through rarely changes the outcome. Ask your doctor directly: “How much time do I have to decide?” Most will say weeks, not days.
First steps that help
- Get copies of your reports: PSA results, biopsy pathology report, and any MRI or scan reports. You will need them for second opinions and for Article 2.
- Bring someone to appointments. A second set of ears catches what you miss. Ask if you can record the conversation.
- Keep one notebook or file for questions, results and names.
- Be careful online. Forums and old websites often describe treatments and outcomes from 20 years ago. Stick to cancer centres, national cancer societies and your care team.
- Tell the people you choose to tell, when you are ready. There is no right timeline.
Questions to ask at your next appointment
- What is my PSA, Grade Group (Gleason score) and stage?
- What risk group does that put me in?
- Do I need more tests, such as an MRI or PSMA PET scan?
- Which treatment options make sense for me, including monitoring?
- Can I meet both a urologist and a radiation oncologist before deciding?
- How much time do I have to decide?
- Is genetic testing recommended for me or my family?
Looking after yourself
Anxiety after a cancer diagnosis is common and treatable. Many cancer centres have counsellors, nurse navigators and support groups for men with prostate cancer. Partners often need support too. Talking with another man who has been through the same decision is one of the most useful things you can do.
Article 2: Making Sense of Your Test Results
Three numbers describe most prostate cancers: your PSA, your Grade Group, and your stage. Together they place you in a risk group, and the risk group guides treatment. Have your reports beside you as you read.
PSA (prostate-specific antigen)
PSA is a protein made by the prostate and measured in a blood test, in nanograms per millilitre (ng/mL). Higher levels can mean cancer, but also an enlarged prostate, infection or recent ejaculation. On its own, PSA does not diagnose cancer. After diagnosis it helps estimate risk, and after treatment it is the main way your team watches for the cancer coming back.
Useful related terms: PSA density (PSA divided by prostate size) and PSA velocity or doubling time (how fast it rises). A rapid rise is more concerning than a single high value.
The biopsy and your Gleason score
A biopsy takes thin cores of tissue, usually 10 to 14, often guided by an MRI. A pathologist grades how abnormal the cancer cells look. The two most common patterns each get a number from 3 to 5, and they are added together: that sum is the Gleason score. Pathologists now also report a simpler Grade Group from 1 to 5.
Gleason score | Grade Group | What it means |
|---|---|---|
3 + 3 = 6 | 1 | Low grade; usually very slow growing |
3 + 4 = 7 | 2 | Mostly low grade, some higher-grade cells |
4 + 3 = 7 | 3 | Mostly higher grade; moderately aggressive |
8 | 4 | High grade |
9 or 10 | 5 | Highest grade; most likely to grow and spread |
Note that 3 + 4 and 4 + 3 both total 7 but behave differently. The first number is the most common pattern, so order matters. Your report may also list how many cores held cancer and what percentage of each core was involved. More cores and higher percentages suggest more cancer.
Stage: where the cancer is
Staging uses the TNM system:
- T (tumour): how far it has grown. T1 cannot be felt on exam; T2 can be felt but is inside the prostate; T3 has grown through the capsule; T4 has reached nearby organs.
- N (nodes): N0 means no spread to lymph nodes; N1 means spread to nearby nodes.
- M (metastasis): M0 means no distant spread; M1 means spread to bone or other organs.
Most men are diagnosed at T1 or T2, N0, M0, which is called localized prostate cancer.
Imaging you may hear about
- Prostate MRI: shows suspicious areas inside the prostate, scored by PI-RADS from 1 (very unlikely to be significant cancer) to 5 (very likely). Also used to guide biopsies and to track cancer on monitoring.
- PSMA PET scan: a newer scan that finds small amounts of prostate cancer outside the prostate more accurately than older bone and CT scans. Usually offered for intermediate- or high-risk cancer, not low-risk.
- Bone scan and CT: older methods for checking spread, still used in many centre’s.
Men with low-risk cancer usually do not need scans to look for spread, because the chance of finding any is very small.
Putting it together: your risk group
Doctors combine PSA, Grade Group and stage into a risk group. The table below is simplified; your team may use finer categories, such as favourable versus unfavourable intermediate risk.
Risk group | Typical findings | What it usually means for treatment |
|---|---|---|
Low | Grade Group 1, PSA under 10, T1 to T2a | Active surveillance is usually the preferred first choice |
Intermediate | Grade Group 2 or 3, or PSA 10 to 20, or T2b to T2c | Surveillance (some favourable cases), surgery or radiation |
High | Grade Group 4 or 5, or PSA over 20, or T3 | Surgery or radiation, often with hormone therapy |
Advanced | Spread to lymph nodes or distant sites | Hormone therapy, usually combined with other drugs or radiation |
One finding can move you up a group. For example, a PSA of 6 with Grade Group 4 is high risk.
Genetic testing
Some men are offered genetic testing, especially with higher-risk cancer or a family history of prostate, breast, ovarian or pancreatic cancer. Inherited changes such as BRCA2 can affect treatment choices and matter for your relatives. Ask whether it is recommended for you.
Article 3: Understanding Your Treatment Options
For localized prostate cancer, the main options control the cancer about equally well; they differ mostly in side effects and in how they fit your life. In the large UK ProtecT trial, men with mostly low- and intermediate-risk cancer were assigned to monitoring, surgery or radiation. After 15 years, about 3% in each group had died of prostate cancer, with no significant difference between groups (NEJM, 2023). That is why choosing treatment is often a question of values, not just medicine.
Active surveillance
Active surveillance means watching the cancer closely and treating only if it shows signs of growing. It typically involves PSA tests every 3 to 6 months, regular MRIs, and repeat biopsies every few years. About a third or more of men eventually move on to treatment, and they keep the chance of cure.
It is the preferred choice for most low-risk cancer and some favourable intermediate-risk cancer. The benefit is avoiding or delaying side effects. The cost is regular testing and, for some men, living with the knowledge of untreated cancer. Active surveillance is different from “watchful waiting,” which is gentler follow-up for older or less healthy men, aimed at managing symptoms rather than cure.
Surgery (radical prostatectomy)
The surgeon removes the whole prostate and seminal vesicles, sometimes with nearby lymph nodes. Most operations today are robot-assisted, with a hospital stay of about a day and a catheter for 1 to 2 weeks.
- Urinary leakage is common at first and improves over months for most men. Pelvic floor exercises help. A small share of men have lasting leakage.
- Erection problems are common. Recovery depends on age, erections before surgery, and whether the nerves could be spared. Medication, devices and injections can help.
- After surgery there is no ejaculate, and orgasm still occurs.
Radiation therapy
- External beam radiation aims high-energy beams at the prostate from outside the body. Modern courses range from 5 treatments (stereotactic body radiotherapy, SBRT) to about 4 to 8 weeks of daily visits.
- Brachytherapy places radioactive seeds or temporary sources inside the prostate.
Side effects include urinary frequency and urgency, bowel irritation, and fatigue during treatment, which mostly settle afterwards. Erection problems tend to develop gradually over years rather than right away. Lasting incontinence is less common than after surgery, but long-term bowel or bladder irritation can occur. Intermediate- and high-risk cancers are often treated with radiation plus a period of hormone therapy.
Hormone therapy (androgen deprivation therapy)
Prostate cancer is fuelled by testosterone. Hormone therapy lowers testosterone or blocks its effects, usually by injection. It is not a cure on its own for localized cancer. It is used alongside radiation for higher-risk cancer, and as the backbone of treatment for advanced cancer, often with newer drugs. Side effects include hot flashes, fatigue, loss of sex drive, weight gain, muscle and bone loss, and mood changes. Exercise helps counter many of them.
Focal therapy
Focal treatments, such as HIFU (high-intensity focused ultrasound) or cryotherapy, treat only the part of the prostate with cancer. They may cause fewer side effects, but long-term evidence is still limited. They are usually offered in specialist centres or trials.
Comparing the main options
| Active surveillance | Surgery | Radiation |
|---|---|---|---|
Best suited to | Low and some intermediate risk | Most localized cancers; often younger, healthy men | Most localized cancers; any age |
Time commitment | Tests every few months, ongoing | One operation; weeks of recovery | 1 to 8 weeks of visits |
Urinary effects | None from treatment | Leakage, improving over months | Frequency and urgency; leakage less common |
Sexual effects | None from treatment | Erection problems early; no ejaculate | Erection problems develop gradually |
Bowel effects | None | Rare | Possible irritation |
If cancer returns | Move to surgery or radiation | Radiation can still be given | Further options exist but are more limited |
How to decide
- Know your risk group (Article 2). It narrows the sensible options.
- See both a urologist and a radiation oncologist. Each tends to favour their own treatment, so hearing both is fair to you.
- Ask each doctor for their own results: rates of incontinence and erection problems in their patients, not national averages.
- Think about what matters most to you: avoiding leakage, protecting sexual function, getting it “out,” avoiding regular tests, or time away from work.
- Get a second opinion on your biopsy if anything is borderline. A pathology review can change the Grade Group.
- Use a decision aid. Many cancer centres provide them, and they are designed for exactly this choice.
There is rarely a single right answer. A good decision is one you make with full information that fits the life you want to live.
Sources
- SEER Cancer Stat Facts: Prostate Cancer, National Cancer Institute
- Understanding localized prostate cancer, Canadian Cancer Society
- Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer, New England Journal of Medicine, 2023